RUSSIA: LIFE-CYCLE INSIGHTS
IPD’s Chinese subscriptions cover the most important products in these market and includes comprehensive tear sheets that highlight:
Drug Information
Regulatory exclusivity
and patent information
Loss-of-exclusivity
scenarios
Biosimilar competitive landscape
API (DMF) information
